Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 7
- US & Canada
DEA Makes Its Final Case for Cannabis Rescheduling as Full Hearing Transcripts Published
As Chief Administrative Law Judge Derek Julius weighs his recommendation on moving cannabis to Schedule III, the DEA’s own closing brief attacks nearly every witness who opposed it — bar one scientist inside its own ranks.
- Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK’s medical cannabis market.
- Interviews
Remexian Surging Ahead One Year On From High Tide Purchase
Whilst expressing empathy with patients impacted by the recent German crackdown on cannabis flower, the head of the country’s leading wholesaler is bullish about its prospects – with orders up 50% since its purchase by Canadian cannabis giant High Tide.
- Cultivation
The Science of the Cannabis Post-Harvest Process
James Duckenfield, CEO of Glass Pharms®, explains the company’s post-harvest process, including drying and curing, and why freeze-drying is never part of it.
- Cultivation
Canopy Focuses On Fundamentals Ditching ‘Financial Instrument’ Era
CANOPY Growth is primed to cull a host of existing brands as it looks to build a multi-market, seed-to-patient model and distance itself from a ‘false starts’ legacy, says CEO Luc Mongeau.
- Interviews
Is It An Open Goal For Germany’s New Cannabis Medicine?
The imminent launch of the first new European cannabis-based pharmaceutical for over five years could not have been better timed, it seems.
- M&A Activity
Aurora Buys UK Pharmacy and Import Licence for £2.1m, Securing ‘Direct Route’ to Patients
As Aurora faces down an unsolicited takeover bid from one of the world’s largest cannabis companies, it has continued to expand its reach in what it sees as the markets of the near future.
- M&A Activity
Aurora Accuses Curaleaf of ‘Pressuring Shareholders’ as it Launches Official Takeover Bid
Curaleaf Holdings has pushed ahead with its unexpected and unsolicited acquisition campaign of Aurora Cannabis and has now submitted an official bid for its Canadian rival.
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- Interviews
Ireland’s Dunbar Pharma Launches First Plant-Derived Dronabinol in UK Through IPS Pharma
Irish pharmaceutical cannabis manufacturer Dunbar Pharmaceuticals has today launched the first plant-derived dronabinol active ingredient into the UK market.
- Medical Cannabis
UK Medical Cannabis Prescriptions Hit 1.7 Million in 2025 as ACMD Review Approaches
More than a year has passed since the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to conduct a formal review of the UK’s medical cannabis industry.
- M&A Activity
Curaleaf’s Aurora Bid Is a Fight for Europe’s Cannabis Crown
Curaleaf Holdings (CURA) announced this week that it intends to launch an unsolicited take-over bid of its rival Aurora Cannabis (ACB) in what would mark one of the most consequential consolidation moves in industry history.
